Your browser doesn't support javascript.
loading
MiR-29c downregulation contributes to metastatic progression in colorectal cancer.
Cristóbal, I; Madoz-Gúrpide, J; Manso, R; Rojo, F; García-Foncillas, J.
Affiliation
  • Cristóbal I; Division of Translational Oncology, Oncohealth Institute jgfoncillas@fjd.es.
  • Madoz-Gúrpide J; Department of Pathology, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain.
  • Manso R; Department of Pathology, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain.
  • Rojo F; Department of Pathology, IIS-Fundacion Jimenez Diaz-UAM, University Hospital 'Fundacion Jimenez Diaz', Madrid, Spain.
  • García-Foncillas J; Division of Translational Oncology, Oncohealth Institute jgfoncillas@fjd.es.
Ann Oncol ; 26(10): 2199-200, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26187445

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Protein Tyrosine Phosphatases / Cell Cycle Proteins / MicroRNAs / Beta Catenin / Membrane Proteins Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Protein Tyrosine Phosphatases / Cell Cycle Proteins / MicroRNAs / Beta Catenin / Membrane Proteins Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article